Today BIOSTEM TECHNOLOGIES INC (OTCMKTS:BSEM) Reported Decrease in Shorted Shares

BioStem Technologies, Inc. (OTCMKTS:BSEM) Logo

The stock of BIOSTEM TECHNOLOGIES INC (OTCMKTS:BSEM) registered a decrease of 2.61% in short interest. BSEM’s total short interest was 11,200 shares in December as published by FINRA. Its down 2.61% from 11,500 shares, reported previously. With 5,000 shares average volume, it will take short sellers 2 days to cover their BSEM’s short positions.

The stock decreased 2.50% or $0.1 during the last trading session, reaching $3.9. About 100 shares traded. BioStem Technologies, Inc. (OTCMKTS:BSEM) has 0.00% since December 6, 2017 and is . It has underperformed by 15.62% the S&P500.

BioStem Technologies, Inc. develops regenerative medicine in the United States, Europe, and South America. The company has market cap of $29.86 million. The Company’s services include nutritionist preparation comprising guided nutritional planning and preparation; conditional testing for allergens and cell optimization; and plasma replacement therapy. It currently has negative earnings. The company's areas of cell therapies comprise cardiovascular disease, arthritis, neuropathic pain, peripheral artery disease, sports and body injuries, and stroke.

More recent BioStem Technologies, Inc. (OTCMKTS:BSEM) news were published by: Globenewswire.com which released: “BioStem Technologies, Inc. Completes 2016, 2017 Audit of Financial Statements – GlobeNewswire” on August 17, 2018. Also Globenewswire.com published the news titled: “BioStem Technologies Inc. Applies for Uplisting to the OTCQX Market – GlobeNewswire” on February 16, 2018. Seekingalpha.com‘s news article titled: “BioStem launches four amniotic products; investors unmoved, shares down 9% – Seeking Alpha” with publication date: October 01, 2018 was also an interesting one.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.